NM_000540.3(RYR1):c.5438G>T (p.Arg1813Met) AND Central core myopathy
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jun 14, 2016
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000395351.5
Allele description [Variation Report for NM_000540.3(RYR1):c.5438G>T (p.Arg1813Met)]
NM_000540.3(RYR1):c.5438G>T (p.Arg1813Met)
Condition(s)
- Name:
- Central core myopathy (CMYO1A)
- Synonyms:
- Central core disease; Central core disease of muscle; Muscle core disease; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007294; MedGen: C0751951; Orphanet: 597; OMIM: 117000
-
vf47g04.r1 Soares mouse NbMH Mus musculus cDNA clone IMAGE:846966 5', mRNA seque...
vf47g04.r1 Soares mouse NbMH Mus musculus cDNA clone IMAGE:846966 5', mRNA sequencegi|2138630|gnl|dbEST|1078010|gb|AA4 .1|Nucleotide
-
vz08e12.r1 Stratagene mouse heart (#937316) Mus musculus cDNA clone IMAGE:131515...
vz08e12.r1 Stratagene mouse heart (#937316) Mus musculus cDNA clone IMAGE:1315150 5', mRNA sequencegi|3054615|gnl|dbEST|1643282|gb|AA9 .1|Nucleotide
-
AV283396 RIKEN full-length enriched, adult male testis (DH10B) Mus musculus cDNA...
AV283396 RIKEN full-length enriched, adult male testis (DH10B) Mus musculus cDNA clone 4933434L04 3', mRNA sequencegi|6276145|gnl|dbEST|3394264|dbj|AV 6.1|Nucleotide
-
AV016619 Mus musculus 18-day embryo C57BL/6J Mus musculus cDNA clone 1110066G02,...
AV016619 Mus musculus 18-day embryo C57BL/6J Mus musculus cDNA clone 1110066G02, mRNA sequencegi|4793611|gnl|dbEST|2511269|dbj|AV 9.1|Nucleotide
-
mc48e07.x1 Soares mouse p3NMF19.5 Mus musculus cDNA clone IMAGE:351780 3', mRNA ...
mc48e07.x1 Soares mouse p3NMF19.5 Mus musculus cDNA clone IMAGE:351780 3', mRNA sequencegi|4258921|gnl|dbEST|2223146|gb|AI4 .1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 16, 2024